Last update:

Oncology news

Most Americans are surviving cancer, but the mental health challenges can persist

An increasing number of Americans are getting—and surviving—cancer. There were more than 18 million cancer survivors in the U.S. in 2025, and the National Cancer Institute estimates that number will grow to 22 million by ...

Radiation therapy enhances immune environment in brain metastases, improving treatment response

A new study led by researchers at The University of Texas MD Anderson Cancer Center demonstrated that preoperative radiation therapy for brain metastases not only targets tumor cells directly but also can activate immune ...

New marker uses tomography to refine gastric cancer prognosis

Researchers at the State University of Campinas (UNICAMP) in São Paulo, Brazil, have identified a new biomarker that may help determine the prognosis for patients with gastric cancer, the fifth most common type of cancer ...

Rural areas lag behind in cancer treatment and prevention

Cancer in the United States experienced a dramatic turnaround in 1991. Prior to that year, cancer deaths had been increasing for decades, peaking at 215 deaths per 100,000 people, meaning about 1 in 4 deaths were attributed ...

FDA expands use of kidney cancer drug belzutifan

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...

AI-powered handheld microscope aims to spot cancer earlier

Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer. The technology, ...

Hidden cell 'message route' could shift cancer research

A team at Huntsman Cancer Institute at the University of Utah (the U) has uncovered a previously unrecognized molecular mechanism by which cells send signals to one another—an insight that could help researchers better understand ...

Novel molecular marker may improve prostate cancer treatment

Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and ...

Public education key in new cervical cancer screening

As Canada moves to modernize cervical cancer screening, a new study suggests most women do not yet understand or trust the shift from the Pap test to human papillomavirus (HPV) based screening. The national survey, published ...

Technology receives FDA approval for breast cancer treatment

More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research into PROTACs (or PROteolysis TArgeting Chimera), a technology that treats certain types of cancer ...